Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin vs oxytocin with or without tranexamic acid to reduce bleeding during cesarean section
IRCT20240529061944N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Apr 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of carbetocin, oxytocin and tranexamic acid (4 arms), sponsored by Kashan University of Medical Sciences. Primary endpoint: Intraoperative and early postoperative bleeding volume. Started Apr 2024; status: completed.
02
Drugs
carbetocinoxytocintranexamic acid
Beyond the preview
Go deeper on IRCT20240529061944N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240529061944N1.